These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
98 related articles for article (PubMed ID: 10394376)
21. Beta-blockers given the go-ahead for treatment of heart failure. McMenemy MC Lancet; 1998 Sep; 352(9130):793. PubMed ID: 9737296 [No Abstract] [Full Text] [Related]
22. Recent clinical data regarding the use of beta blockers in heart failure: focus on CIBIS II. Dargie H Heart; 1999 Dec; 82 Suppl 4(Suppl 4):IV2-4. PubMed ID: 10574902 [No Abstract] [Full Text] [Related]
23. [Beta1-adrenergic receptor (Arg389Gly) polymorphism and response to bisoprolol in patients with chronic heart failure]. Yu WP; Lou M; Deng B; Song HM; Wang HB Zhonghua Xin Xue Guan Bing Za Zhi; 2006 Sep; 34(9):776-80. PubMed ID: 17217681 [TBL] [Abstract][Full Text] [Related]
24. The role of beta-blockade in modern cardiovascular therapy. Proceedings of the 3rd International Symposium on Bisoprolol. Barcelona, Spain, September 29-October 1, 1989. J Cardiovasc Pharmacol; 1990; 16 Suppl 5():S1-212. PubMed ID: 11572202 [No Abstract] [Full Text] [Related]
25. The Cardiac Insufficiency Bisoprolol Study II. Drummond GA; Squire IB Lancet; 1999 Apr; 353(9161):1361. PubMed ID: 10218556 [No Abstract] [Full Text] [Related]
26. [Drug of the month. Maxsoten]. Kulbertus H Rev Med Liege; 1996 May; 51(5):382-4. PubMed ID: 8992562 [No Abstract] [Full Text] [Related]
27. Selective beta-blockers and mortality from heart failure. Seth S; Naik N; Mohan A Natl Med J India; 1999; 12(5):225-6. PubMed ID: 10613003 [No Abstract] [Full Text] [Related]
28. Design of the cardiac insufficiency bisoprolol study II (CIBIS II). The CIBIS II Scientific Committee. Fundam Clin Pharmacol; 1997; 11(2):138-42. PubMed ID: 9107560 [TBL] [Abstract][Full Text] [Related]
29. Bisoprolol in heart failure. Drummond G Hosp Med; 2000 Apr; 61(4):289. PubMed ID: 10858813 [No Abstract] [Full Text] [Related]
30. Differences between beta-blockers in patients with chronic heart failure and chronic obstructive pulmonary disease: a randomized crossover trial. Jabbour A; Macdonald PS; Keogh AM; Kotlyar E; Mellemkjaer S; Coleman CF; Elsik M; Krum H; Hayward CS J Am Coll Cardiol; 2010 Apr; 55(17):1780-7. PubMed ID: 20413026 [TBL] [Abstract][Full Text] [Related]
31. Effects of bisoprolol in patients with stable congestive heart failure. de Groote P; Delour P; Lamblin N; Dagorn J; Verkindère C; Tison E; Millaire A; Bauters C Ann Cardiol Angeiol (Paris); 2004 Jul; 53(4):167-70. PubMed ID: 15369311 [TBL] [Abstract][Full Text] [Related]
32. Using Cardicor as first-line therapy in heart failure : CiBis iii. Cardiovasc J Afr; 2009; 20(1):78. PubMed ID: 19382368 [No Abstract] [Full Text] [Related]
33. [Adaptation of guidelines for the treatment of chronic heart failure in a specialized heart failure clinic]. Pölzl G; Gouya G; Hügel H; Frick M; Ulmer H; Pachinger O Wien Klin Wochenschr; 2002 Oct; 114(19-20):833-9. PubMed ID: 12503474 [TBL] [Abstract][Full Text] [Related]
34. Review of the Cardiac Insufficiency Bisoprolol Study II (CIBIS-II). LeJemtel TH Curr Cardiol Rep; 1999 May; 1(1):29-30. PubMed ID: 10980816 [No Abstract] [Full Text] [Related]
35. [Risk reduction of acute heart failure with initial administration of beta-blockers]. Med Monatsschr Pharm; 2007 Apr; 30(4):158. PubMed ID: 17484449 [No Abstract] [Full Text] [Related]
36. Which beta-blocker for heart failure? Patel MR; Gattis W Am Heart J; 2004 Feb; 147(2):238. PubMed ID: 14760319 [No Abstract] [Full Text] [Related]